Contact this trialFirst, we need to learn more about you.
Janus Kinase Inhibitor
Abrocitinib for Long COVID Fatigue
Recruiting0 awardsPhase 2
Boston, Massachusetts
"This trial will test if abrocitinib can reduce severe fatigue in non-hospitalized adults with Long COVID. Participants will receive either abrocitinib or a placebo for 12 weeks to see
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service